Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Increased by Exome Asset Management LLC

Exome Asset Management LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 16.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,427 shares of the medical equipment provider's stock after purchasing an additional 1,069 shares during the period. Intuitive Surgical accounts for 2.4% of Exome Asset Management LLC's investment portfolio, making the stock its 13th biggest position. Exome Asset Management LLC's holdings in Intuitive Surgical were worth $3,649,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Ridgewood Investments LLC purchased a new stake in Intuitive Surgical in the 2nd quarter valued at about $26,000. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 35 shares during the period. LGT Financial Advisors LLC increased its position in Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock worth $30,000 after purchasing an additional 54 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical during the third quarter worth approximately $33,000. Finally, Mark Sheptoff Financial Planning LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at $37,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 108 shares of the firm's stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the business's stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares of the company's stock, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 in the last ninety days. Corporate insiders own 0.90% of the company's stock.

Intuitive Surgical Price Performance

ISRG traded down $5.14 on Friday, reaching $539.58. The company's stock had a trading volume of 1,071,762 shares, compared to its average volume of 1,439,538. Intuitive Surgical, Inc. has a 1 year low of $320.26 and a 1 year high of $556.23. The business's 50 day moving average is $521.82 and its 200 day moving average is $479.00. The stock has a market cap of $192.19 billion, a price-to-earnings ratio of 86.75, a price-to-earnings-growth ratio of 5.35 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analysts' expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on ISRG shares. Citigroup increased their target price on Intuitive Surgical from $567.00 to $640.00 and gave the stock a "buy" rating in a research report on Wednesday. Leerink Partners raised their price objective on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Tuesday, November 19th. BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a research report on Tuesday, November 26th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an "overweight" rating in a research report on Friday, October 11th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $550.28.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.